Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis.
Neurology of inherited glycosylation disorders.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
17β-estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Cesarean section and offspring's risk of multiple sclerosis: a Danish nationwide cohort study.
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.
An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.
Epigenetic in Multiple Sclerosis: Molecular mechanisms and dietary intervention.
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Panic disorder as presenting symptoms of multiple sclerosis.
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis).
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
Frequent Infection of Neurons by SV40 Virus in SIV-Infected Macaque Monkeys with Progressive Multifocal Leukoencephalopathy and Meningoencephalitis.
Superficial brain stimulation in multiple sclerosis.
Antigen-specific tolerization approaches in multiple sclerosis.
[Illness, health and sunlight].
A methylenetetrahydrofolate reductase gene polymorphism in multiple sclerosis.
Russell W Brain and the aetiology of multiple sclerosis--a historical perspective.
Recent onset disequilibrium mimicking acute vestibulopathy in early multiple sclerosis.
Pages
« first
‹ previous
…
590
591
592
593
594
595
596
597
598
…
next ›
last »